Obstetrics/Gynecology General
RSSArticles
-
Abortion-Providing Clinicians Are Shifting Careers and Locations to Meet Needs
Clinicians in the study included nurses, advanced practice practitioners, and clinicians in family medicine.
-
The Cancer-Prevention Benefits of Opportunistic Bilateral Salpingectomies
As increasing numbers of patients seek permanent contraception in the United States, it is clinically important for OB/GYNs to talk with them about an important health benefit of bilateral salpingectomy, which is a safe procedure for both permanent contraception and to prevent ovarian cancer, research shows.
-
Updates on Cervical Cancer Prevention: Summary and Projected Effect
HPV vaccination and updated screening strategies offer OB/GYN providers powerful tools to prevent cervical cancer. Recent advances, risk-based management, and enhanced follow-up can provide targeted care for high-risk patients to reduce the incidence of cervical cancer while avoiding unnecessary procedures.
-
Postoperative Antibiotics After Cesarean Delivery to Reduce SSI
This randomized, double-blind clinical trial including 321 women with a pre-pregnancy body mass index > 30 kg/m2 demonstrated no difference in surgical site infection composite between participants receiving oral cephalexin and metronidazole for 48 hours after cesarean delivery compared to placebo (5.6% vs. 6.8%; odds ratio, 0.80; 95% confidence interval, 0.33-2.22; P = 0.64).
-
Adverse Outcomes in Women with a History of Recurrent Pregnancy Loss
Women with a history of recurrent pregnancy loss are at significantly increased risk of adverse outcomes, including preeclampsia, placental abruption, cesarean delivery, preterm birth, stillbirth, and perinatal mortality.
-
What Is the Genitourinary Syndrome of Lactation?
In this systematic review of 65 studies, the prevalence of vaginal atrophy among postpartum breastfeeding patients was 63.9% (95% confidence interval [CI], 55.3% to 71.6%) and vaginal dryness symptoms occurred in 53.6% (95% CI, 33.6% to 72.5%). Dyspareunia also was elevated, with a prevalence of 60.0% at three months, (95% CI, 45.1% to 73.3%), 39.7% at six months, (95% CI, 28.9% to 51.5%), and 28.5% at 12 months (95% CI, 26.3% to 30.9%).
-
Evaluation and Management of Abnormal Uterine Bleeding in Nonpregnant Patients: A Detailed Review
Vaginal bleeding in the nonpregnant patient may be due to various etiologies, including structural abnormalities, dysfunctional bleeding, disorders of menstruation, trauma, or coagulopathy. Emergency department assessment and management includes a thorough history and physical examination, stabilization, diagnostic studies, treatment, and appropriate disposition.
-
Clinicians Need to Know More About the Menstrual Health Apps Patients Use
Period-tracking apps are increasingly popular among reproductive-age women in the United States and elsewhere in the world. A new study suggests that healthcare providers should educate themselves about the apps’ functionality, inclusiveness, and health education information before recommending a menstrual app to patients.
-
Changes in Postpartum Permanent Contraception Decision-Making
Requests for permanent contraception among women have increased since June 2022. OB/GYNs report in a new study that their patients often bring up threats to their reproductive health autonomy as a reason for requesting a permanent contraception procedure.
-
Gepotidacin Tablets (Blujepa)
The U.S. Food and Drug Administration has approved gepotidacin, a first-in-class antibacterial medication for the treatment of uncomplicated urinary tract infections. It is the first new class of oral antibiotics approved in nearly 30 years.